Abstract
The study is aimed at examining changes in economic burden in comparison with figures cited in previous studies. Data from South Korea’s National Health Insurance claims database are used to measure the economic burden of chronic disease. Both direct and indirect costs are considered. Direct costs are those associated directly with treatment, medication, and transportation, and indirect costs are assessed in terms of the loss of productivity and their caregivers and consist of morbidity and mortality costs. We also undertake sensitivity analysis, wherein we extract incidence cases and categorize them in terms of their frequency of hospital visits (from one time to five times). The total economic burden posed by chronic disease in South Korea in 2010 was found to be approximately 3.7 million USD; indirect costs and direct medical costs accounted for most of the economic burden, although the rates of these varied from disease to disease. In a comparison of disability-adjusted life years values and the economic burden of diseases, diseases varied widely in terms of their burden. The findings of this study can be used to inform policymakers as they establish public health policies that address various disease burden indexes. Key words: Chronic illness, economic analysis, measurement.
Highlights
As of 2010, worldwide, chronic diseases such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes accounted for 60% of all deaths worldwide (35 million), and 80% or more of all deaths in developing and underdeveloped countries (WHO, 2005)
We found the total economic burden incurred in that year by the presence of chronic disease to be approximately 3.7 million U.S dollars (USD) indirect and direct medical costs accounted for the greatest proportion of the overall economic burden, these values varied from disease to disease
An approximately USD8.2-billion economic burden was associated with malignant cancer, a disease that accounted for the greatest proportion of economic burden; this was followed closely by the USD 7.88 billion burden associated with cardiocerebrovascular diseases
Summary
Sensitivity analysis of the economic burden using social insurance claim data Sung-Won Jung and Eun-Jung Kim1*. Data from South Korea’s National Health Insurance claims database are used to measure the economic burden of chronic disease. Both direct and indirect costs are considered. The total economic burden posed by chronic disease in South Korea in 2010 was found to be approximately 3.7 million USD; indirect costs and direct medical costs accounted for most of the economic burden, the rates of these varied from disease to disease. In a comparison of disability-adjusted life years values and the economic burden of diseases, diseases varied widely in terms of their burden.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
